Rodríguez GD

Language: Spanish
References: 21
Page: 370-378
PDF size: 72.64 Kb.

ABSTRACT

The diabetic foot is the result of the interaction of systemic or predisposing factors (Neuropathy, Microangiopathy and Macroangiopathy) upon which unleashing aggravating factors also act. With the objective of evaluating the implications of traumatism in the physiopathology of the diabetic foot, literature review was made in national and international databases to analyze the papers published until 2011. The terms were definition, concept, traumatism and physiopathology of the diabetic foot in Spanish and English. It was verified that traumatism is generally addressed in this disease as part of the extrinsic unleashing factors that are classified into mechanical, thermal or chemical, which is supported on five definitions of this disease, one of them put forward by a domestic author. It was concluded that the restricted interpretation of the implication of traumatism for the physiopathology of the diabetic foot together with poor interpretation of this factor in the various concepts already known makes it possible to prepare a new definition of this disease.

REFERENCES

1. Barcelo A, Rajpathak S. Incidence and Prevalence of diabetes mellitus in the Americas. Rev Panam Sal. 2001;10(5):300-7.

2. González de la Torre H, Perdomo Pérez E, Quintana L, Mosquera Fernández A. Estratificación del riesgo en Pie Diabético. Gerocomos [Internet]. 2010 [citado 13 sep 2013];21(4):172-82. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-928X2010000400006

3. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetol [Internet]. 2008 [citado 13 sep 2013];51(5):747-55. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292424/

4. Rivero Fernández F, Conde Pérez A, Varela Hernández A, Vejerano García P, Socarrás Olivera N, Otero Reyes M, et al. Resultados de un modelo de atención preventiva del pie diabético en la comunidad. Rev Cubana Angiol Cir Vasc [Internet]. 2006 [citado 24 abr 2009];7(1) Disponible en: http://bvs.sld.cu/revistas/ang/vol7_1_06/ang01106.htm

5. Marinello RJ, Blanes MJL, Escudero RJR, Ibáñez EV, Rodríguez OJ. Tratado de Pie Diabético. Madrid: Jarpyo; 2002. Revista Cubana de Medicina Militar 2014;43(3):370-378 - http://scielo.sld.cu 377

6. Flack S, Apelqvist J, Keith M, Trueman P, Williams D. An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers. J Wound Care [Internet]. 2008 [citado 13 sep 2013];17(2):71-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18389832

7. Frykberg RG, Belczyk R. Epidemiology of the Charcot foot. Clin Podiatr Med Surg. 2008;25(1):17-28.

8. Soldevilla JJ. Presentación del Documento Nacional de Consenso sobre Úlceras de la Extremidad Inferior (CONUEI): la historia continua. Anales Patol Vasc [Internet]. 2009 [citado 10 sep 2011];3(1):[aprox. 20 p.]. Disponible en: http://www.nexusmedica.com/web/sumario_anteriores.php?Ano=2009&Numero=1&i d_revista=668&fano=2009&fnumero=1&ffemede=&sol=1

9. García A, Pardo G. Cirugía. T 2. La Habana: Editorial Ciencias Médicas; 2006. p. 539-47.

10. Lowry SF. Cytokine mediators of immunity and inflammation. Arch Surg. 1993;128:1235-41.

11. Trunkey DD. Inflammation and trauma. Arch Surg. 1988;123:1517-8.

12. Asociación Española de Cirujanos, Sociedad Española de Angiología y Cirugía Vascular, Sociedad Española de Medicina Interna y Sociedad Española de Quimioterapia. Documento de consenso sobre el tratamiento antimicrobiano de las infecciones en el pié diabético. Angiología [Internet]. 2008 [citado 10 sep 2011];60(2):[Aprox. 15 p.]. Disponible en: http://www.elsevier.es/en/node/2457145

13. Fleischer AE, Didyk AA, Woods JB, Burns SE, Wrobel JS, Armstrong DG. Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot. J Foot Ankle Surg. 2009;48(1):39-46.

14. Valabhji J, Oliver N, Samarasinghe D, Mali T, Gibbs RG, Gedroyc WM. Conservative management of diabetic forefoot ulceration complicated by underlying osteomyelitis: the benefits of magnetic resonance imaging. Diabet Med. 2009 Nov;26(11):1127-34.

15. Lesens O, Desbiez F, Vidal M, Robin F, Descamps S, Beytout J, et al. Culture of per-wound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis. Clin Microbiol Infect. 2011 Feb;17(2):285-91.

16. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. Infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun;54(12):e132-73.

17. American Diabetes Association. Standards of medical care in diabetes 2011. Diabetes Care. 2011 Jan;34(Suppl 1):S11-61.

18. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008 May;51(5):747-55. Revista Cubana de Medicina Militar 2014;43(3):370-378 - http://scielo.sld.cu 378

19. Beltrán Ramón J, Ruiz Sánchez C, Miquel Abbad C. Fisiopatología, clínica y tratamiento del pie diabético. Angiología. 1989;6:217-24.

20. International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot and Practical Guidelines on the Management and Prevention of the Diabetic Foot 2007 [CD-ROM]. Ámsterdam: Consultative Section of the International Diabetes Federation; 2007.

21. McCook Martínez J. Pie diabético. Epidemiología. Rev Cubana Hig Epidemiol. 1979;17:163-73.